
London-based group backing and growing science and technology companies in life sciences, deep tech and cleantech

Venture philanthropy fund of JDRF investing in companies developing treatments and technology for type 1 diabetes

JDRF T1D Fund is a venture philanthropy fund that invests in companies working on type 1 diabetes. It is part of JDRF, the diabetes research charity. The fund looks for commercial viability rather than the pure learning that a basic research grant supports.
Early-stage biotech and medtech businesses in diabetes. Its news mentions Inversago Pharma, Veralox Therapeutics, and Capillary Biomedical, an infusion set developer later acquired by Tandem Diabetes Care.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about JDRF T1D Fund.
Similar listings buyers compare against this one.

London-based group backing and growing science and technology companies in life sciences, deep tech and cleantech

Venture firm funding entrepreneurs who bring technology to retail and consumer brands

Investment banking, markets and research arm of Bank of America serving corporations and institutions

Early-stage technology investor backing unconventional startups through a syndicate and a rolling fund

An investor in early-stage hard-science startups working on materials, chemistry and engineering

Technology venture firm investing early in US and Asian companies with cross-Pacific potential
Everything here links back to the same verified catalogue. Pick your next stop.